Published in BMC Nephrol on June 16, 2014
Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease-A Propensity Score Analysis. PLoS One (2015) 0.84
Predictors and the Subsequent Risk of End-Stage Renal Disease - Usefulness of 30% Decline in Estimated GFR over 2 Years. PLoS One (2015) 0.80
Time-dependent risk factors associated with the decline of estimated GFR in CKD patients. Clin Exp Nephrol (2015) 0.78
Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review. PLoS One (2017) 0.77
The Relation of Moderate Alcohol Consumption to Hyperuricemia in a Rural General Population. Int J Environ Res Public Health (2016) 0.75
Association of renal function with clinical parameters and conditions in a longitudinal population-based epidemiological study. Biomed Rep (2016) 0.75
Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based study. World J Nephrol (2017) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA (2008) 5.59
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis (2006) 4.26
Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol (2008) 3.42
Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol (2007) 3.06
Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis (2004) 2.73
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis (2004) 2.28
Effect of allopurinol on blood pressure: a systematic review and meta-analysis. J Clin Hypertens (Greenwich) (2012) 2.16
Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2011) 2.14
Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int (2005) 2.02
EBPG guideline on dialysis strategies. Nephrol Dial Transplant (2007) 1.90
Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol (2000) 1.78
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol (2008) 1.68
Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis (2010) 1.65
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant (2013) 1.47
Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol (2002) 1.39
Effects of acute and chronic L-arginine treatment in experimental hyperuricemia. Am J Physiol Renal Physiol (2006) 1.33
Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol (2008) 1.25
Section I. Measurement of renal function, when to refer and when to start dialysis. Nephrol Dial Transplant (2002) 1.24
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care (2011) 1.23
Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients. Nephrol Dial Transplant (2009) 1.11
Uric acid levels predict future development of chronic kidney disease. Am J Nephrol (2011) 1.10
Hyperuricaemia and accelerated reduction in renal function. Scand J Rheumatol (2010) 1.05
Multiple imputation: dealing with missing data. Nephrol Dial Transplant (2013) 0.93
The association between plasma uric acid and renal function decline in a Chinese population-based cohort. Nephrol Dial Transplant (2011) 0.92
Uric acid, hypertension, and cardiovascular and renal complications. Curr Hypertens Rep (2013) 0.89
High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant (2007) 2.91
Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA (2009) 2.85
Newborn hearing screening vs later hearing screening and developmental outcomes in children with permanent childhood hearing impairment. JAMA (2010) 2.80
Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant (2009) 2.69
Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant (2010) 2.64
Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. Nephrol Dial Transplant (2007) 2.53
The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis (2004) 2.40
A regression model with unexplained residuals was preferred in the analysis of the fetal origins of adult diseases hypothesis. J Clin Epidemiol (2005) 2.39
Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int (2008) 2.36
Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ (2006) 2.29
Time-dependent reasons for peritoneal dialysis technique failure and mortality. Perit Dial Int (2010) 2.17
Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. J Am Soc Nephrol (2005) 2.16
Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int (2002) 2.12
When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant (2013) 1.95
Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant (2010) 1.90
CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol (2009) 1.88
A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. J Clin Endocrinol Metab (2004) 1.87
Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int (2003) 1.87
Tuning research competences for Bologna three cycles in medicine: report of a MEDINE2 European consensus survey. Perspect Med Educ (2013) 1.87
Social support predicts survival in dialysis patients. Nephrol Dial Transplant (2006) 1.84
The effect of joint exposures: examining the presence of interaction. Kidney Int (2009) 1.78
Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant (2006) 1.76
The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2. Am J Kidney Dis (2003) 1.66
Effect of intrauterine growth restriction on kidney function at young adult age: the Nord Trøndelag Health (HUNT 2) Study. Am J Kidney Dis (2008) 1.64
Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol (2004) 1.62
Renal function and size at young adult age after intrauterine growth restriction and very premature birth. Am J Kidney Dis (2007) 1.61
Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2012) 1.61
The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis (2005) 1.60
Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant (2003) 1.56
Association of ethnicity and survival in peritoneal dialysis: a cohort study of incident patients in Brazil. Am J Kidney Dis (2013) 1.51
Comparison of the SF-36 Five-item Mental Health Inventory and Beck Depression Inventory for the screening of depressive symptoms in chronic dialysis patients. Nephrol Dial Transplant (2012) 1.49
How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis (2002) 1.49
Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol (2003) 1.48
Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis? J Intern Med (2013) 1.47
Scientific output of Dutch medical students. Med Teach (2010) 1.47
Sample size calculations: basic principles and common pitfalls. Nephrol Dial Transplant (2010) 1.47
Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr (2009) 1.46
Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis (2006) 1.46
Associations between prenatal and infancy weight gain and BMI, fat mass, and fat distribution in young adulthood: a prospective cohort study in males and females born very preterm. Am J Clin Nutr (2005) 1.41
The MDRD formula does not reflect GFR in ESRD patients. Nephrol Dial Transplant (2010) 1.38
Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects. Diabetes Care (2007) 1.36
Favorable glucose tolerance and lower prevalence of metabolic syndrome in offspring without diabetes mellitus of nonagenarian siblings: the Leiden longevity study. J Am Geriatr Soc (2010) 1.33
Statistical methods for the assessment of prognostic biomarkers(part II): calibration and re-classification. Nephrol Dial Transplant (2010) 1.29
Obesity and mortality risk among younger dialysis patients. Clin J Am Soc Nephrol (2012) 1.29
Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit. Br J Clin Pharmacol (2013) 1.28
Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study. Am J Kidney Dis (2008) 1.27
Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. Am J Kidney Dis (2012) 1.26
The influence of COPD on health-related quality of life independent of the influence of comorbidity. J Clin Epidemiol (2003) 1.24
Height, weight, body mass index and pubertal development reference values for children of Turkish origin in the Netherlands. Eur J Pediatr (2003) 1.23
The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method. Nephrol Dial Transplant (2010) 1.23
Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant (2011) 1.22
Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant (2006) 1.19
Arteriovenous access failure: more than just intimal hyperplasia? Nephrol Dial Transplant (2013) 1.18
Severe bone disease and low bone mineral density after juvenile renal failure. Kidney Int (2003) 1.18
Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol (2007) 1.18
Selection bias and information bias in clinical research. Nephron Clin Pract (2010) 1.17
Interactive seminars or small group tutorials in preclinical medical education: results of a randomized controlled trial. BMC Med Educ (2010) 1.16
Adjustment for comorbidity in studies on health status in ESRD patients: which comorbidity index to use? J Am Soc Nephrol (2003) 1.16
Sample size calculations. Nephron Clin Pract (2011) 1.14
Is blood pressure increased 19 years after intrauterine growth restriction and preterm birth? A prospective follow-up study in The Netherlands. Pediatrics (2005) 1.14
The analysis of survival data in nephrology: basic concepts and methods of Cox regression. Kidney Int (2008) 1.14
Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol (2011) 1.13
Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. J Lipid Res (2007) 1.11
The analysis of survival data: the Kaplan-Meier method. Kidney Int (2008) 1.10
Behavioural research in patients with end-stage renal disease: a review and research agenda. Patient Educ Couns (2009) 1.10
Agreement between methods. Kidney Int (2008) 1.10
Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients. Nephrol Dial Transplant (2010) 1.09
Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10. Breast Cancer Res (2011) 1.09
Very preterm birth is associated with disabilities in multiple developmental domains. J Pediatr Psychol (2005) 1.08
The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model. Rev Med Virol (2013) 1.07
A practical approach to Bland-Altman plots and variation coefficients for log transformed variables. J Clin Epidemiol (2008) 1.06
Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. BMC Nephrol (2011) 1.04
Illness perceptions in dialysis patients and their association with quality of life. Psychol Health (2008) 1.04
Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int (2004) 1.04
Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients. Kidney Int (2009) 1.03
Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol (2011) 1.03
Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant (2008) 1.03
The diagnostic work up of growth failure in secondary health care; an evaluation of consensus guidelines. BMC Pediatr (2008) 1.02
Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol (2007) 1.02
A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients. Nephrol Dial Transplant (2008) 1.02
Survival analysis I: the Kaplan-Meier method. Nephron Clin Pract (2011) 1.00
Very preterm birth is a risk factor for increased systolic blood pressure at a young adult age. Pediatr Nephrol (2009) 1.00
Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J Am Soc Nephrol (2004) 1.00
When to start dialysis treatment: where do we stand? Perit Dial Int (2005) 1.00
Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients. Clin J Am Soc Nephrol (2010) 0.99
Diagnostic methods 2: receiver operating characteristic (ROC) curves. Kidney Int (2009) 0.99
Cohort studies: prospective versus retrospective. Nephron Clin Pract (2009) 0.98
Reduced renal length and volume 20 years after very preterm birth. Pediatr Nephrol (2009) 0.98
Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes. Transplantation (2007) 0.98
The issue of studying the effect of interventions in renal replacement therapy -- to what extent may we be deceived by selection and competing risk? Nephrol Dial Transplant (2010) 0.97
Testing for causality and prognosis: etiological and prognostic models. Kidney Int (2008) 0.97
Timing of group B streptococcus screening in pregnancy: a systematic review. Gynecol Obstet Invest (2009) 0.97
The association of depressive symptoms with survival in a Dutch cohort of patients with end-stage renal disease. Nephrol Dial Transplant (2009) 0.97
Low cholesterol in dialysis patients--causal factor for mortality or an effect of confounding? Nephrol Dial Transplant (2011) 0.96
Symptom clusters in incident dialysis patients: associations with clinical variables and quality of life. Nephrol Dial Transplant (2008) 0.96
Sex differences in the impact of diabetes on mortality in chronic dialysis patients. Nephrol Dial Transplant (2010) 0.96
Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clin J Am Soc Nephrol (2011) 0.95
Illness perceptions and treatment perceptions of patients with chronic kidney disease: different phases, different perceptions? Br J Health Psychol (2012) 0.95
Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. Nephrol Dial Transplant (2007) 0.95
Predictors of survival in anuric peritoneal dialysis patients. Kidney Int (2005) 0.94